EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant

Anneka E Blankenship, Lauren Yoksh, Paul J Kueck, Jonathan D Mahnken, Jill K Morris, Aditi Gupta iD

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2024-07 · 16 (3)

DOI: 10.1002/dad2.12614 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 03.07.2024. Verfasst von Anneka E Blankenship und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center Fairway Kansas USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) blood biomarkers show promise for clinical diagnosis but their reliability in chronic kidney disease (CKD) is debated. This study investigates the impact of kidney transplant (KT) on AD biomarkers in CKD. METHODS We assessed AD biomarkers in 46 CKD patients pre‐KT, at 12 weeks and 12 months post‐KT, with baseline measures from 13 non‐CKD controls. Using linear mixed models, we examined associations with participant groups, estimated glomerular filtration rate (eGFR) and cognition. RESULTS CKD patients showed elevated levels of neurofilament light (117 ± 72 vs. 11 ± 5 pg/mL), phosphorylated tau 181 (75 ± 42 vs. 13 ± 8 pg/mL), glial fibrillary acidic protein (193 ± 127 vs. 94 ± 39 pg/mL), amyloid β 42 (17 ± 5 vs. 5 ± 1 pg/mL), and amyloid β 40 (259 ± 96 vs. 72 ± 17 pg/mL) compared to controls. Post‐KT, biomarker levels approached normal with improved eGFR, paralleled by enhanced cognitive function. DISCUSSION AD blood biomarker elevations in CKD are reversible with improved kidney function through KT. Highlights AD biomarker levels are extremely high in severe CKD. AD biomarker levels are higher in patients with kidney failure on dialysis when compared to CKD patients not on dialysis. These elevations in AD biomarker levels in kidney failure are reversable and decrease dramatically after kidney transplantation. The change in biomarker levels after transplantation align with changes in kidney function. The change in biomarker levels after transplantation align with changes in cognitive function.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid betabiomarkerschronic kidney diseasecognitionestimated glomerular filtrationglial fibrillary acidic proteinkidney transplantneurofilament lightphosphorylated tauvascular dementia

Autor:innen und Institutionen

  • University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center Fairway Kansas USA.
  • Department of Neurology University of Kansas Medical Center Kansas City Kansas USA.
  • Department of Biostatistics & Data Science University of Kansas Medical Center Kansas City Kansas USA.
  • Frontiers Clinical & Translational Science Institute, University of Kansas Medical Center Fairway Kansas USA.
  • Division of Nephrology and Hypertension Department of Internal Medicine University of Kansas Medical Center Kansas City Kansas USA.

ORCID-Profile: Aditi Gupta

Förderung

  • NIA NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Blankenship, A. E., Yoksh, L., Kueck, P. J., Mahnken, J. D., Morris, J. K., & Gupta, A. (2024). Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 16(3). https://doi.org/10.1002/dad2.12614

Vancouver

Blankenship AE, Yoksh L, Kueck PJ, Mahnken JD, Morris JK, Gupta A. Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2024;16(3). doi:10.1002/dad2.12614

BibTeX
@article{Blankenship2024,
  author = {Blankenship, Anneka E and Yoksh, Lauren and Kueck, Paul J and Mahnken, Jonathan D and Morris, Jill K and Gupta, Aditi},
  title = {Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant},
  journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
  year = {2024},
  volume = {16},
  number = {3},
  doi = {10.1002/dad2.12614}
}
Kostenlos starten →